BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li J, Guan X, Fan Z, Ching LM, Li Y, Wang X, Cao WM, Liu DX. Non-Invasive Biomarkers for Early Detection of Breast Cancer. Cancers (Basel) 2020;12:E2767. [PMID: 32992445 DOI: 10.3390/cancers12102767] [Cited by in Crossref: 8] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Darie-ion L, Whitham D, Jayathirtha M, Rai Y, Neagu A, Darie CC, Petre BA. Applications of MALDI-MS/MS-Based Proteomics in Biomedical Research. Molecules 2022;27:6196. [DOI: 10.3390/molecules27196196] [Reference Citation Analysis]
2 Clases D, Gonzalez de Vega R. Facets of ICP-MS and their potential in the medical sciences—Part 2: nanomedicine, immunochemistry, mass cytometry, and bioassays. Anal Bioanal Chem. [DOI: 10.1007/s00216-022-04260-8] [Reference Citation Analysis]
3 Sarvari P, Sarvari P, Ramírez-díaz I, Mahjoubi F, Rubio K. Advances of Epigenetic Biomarkers and Epigenome Editing for Early Diagnosis in Breast Cancer. IJMS 2022;23:9521. [DOI: 10.3390/ijms23179521] [Reference Citation Analysis]
4 Alkhaleefah M, Tan TH, Chang CH, Wang TC, Ma SC, Chang L, Chang YL. Connected-SegNets: A Deep Learning Model for Breast Tumor Segmentation from X-ray Images. Cancers (Basel) 2022;14:4030. [PMID: 36011022 DOI: 10.3390/cancers14164030] [Reference Citation Analysis]
5 Wang C, Xie X, Li W, Jiang D. Expression of KIF2A, NDC80, CDK1, and CCNB1 in breast cancer patients: Their interaction and linkage with tumor features and prognosis. J Clin Lab Anal 2022;:e24647. [PMID: 35949045 DOI: 10.1002/jcla.24647] [Reference Citation Analysis]
6 Chen Q, Yang SB, Zhang YW, Han SY, Jia L, Li B, Zhang Y, Zuo S. miR-3682-3p directly targets FOXO3 and stimulates tumor stemness in hepatocellular carcinoma via a positive feedback loop involving FOXO3/PI3K/AKT/c-Myc. World J Stem Cells 2022; 14(7): 539-555 [DOI: 10.4252/wjsc.v14.i7.539] [Reference Citation Analysis]
7 Carvalho TM, Brasil GO, Jucoski TS, Adamoski D, Lima RSD, Spautz CC, Anselmi KF, Ozawa PMM, Cavalli IJ, Carvalho de Oliveira J, Gradia DF, Ribeiro EMDSF. MicroRNAs miR-142-5p, miR-150-5p, miR-320a-3p, and miR-4433b-5p in Serum and Tissue: Potential Biomarkers in Sporadic Breast Cancer. Front Genet 2022;13:865472. [DOI: 10.3389/fgene.2022.865472] [Reference Citation Analysis]
8 van der Poort EKJ, van Ravesteyn NT, van den Broek JJ, de Koning HJ. The Early Detection of Breast Cancer Using Liquid Biopsies: Model Estimates of the Benefits, Harms, and Costs. Cancers (Basel) 2022;14:2951. [PMID: 35740615 DOI: 10.3390/cancers14122951] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Liu S, Wang J. Current and Future Perspectives of Cell-Free DNA in Liquid Biopsy. Curr Issues Mol Biol 2022;44:2695-709. [PMID: 35735625 DOI: 10.3390/cimb44060184] [Reference Citation Analysis]
10 Matsuzaka Y, Yashiro R. Therapeutic Strategy of Mesenchymal-Stem-Cell-Derived Extracellular Vesicles as Regenerative Medicine. Int J Mol Sci 2022;23:6480. [PMID: 35742923 DOI: 10.3390/ijms23126480] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Najafi S. Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials. Int J Biol Macromol 2022;206:939-53. [PMID: 35318084 DOI: 10.1016/j.ijbiomac.2022.03.103] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Marchetti M, Russo L, Giaccherini C, Gamba S, Falanga A. Hemostatic system activation in breast cancer: Searching for new biomarkers for cancer risk prediction and outcomes. Thrombosis Research 2022;213:S46-50. [DOI: 10.1016/j.thromres.2022.01.019] [Reference Citation Analysis]
13 Beksac K, Reçber T, Çetin B, Alp O, Kaynaroğlu V, Kır S, Nemutlu E. GC-MS Based Metabolomics Analysis to Evaluate Short-Term Effect of Tumor Removal on Patients with Early-Stage Breast Cancer. J Chromatogr Sci 2022:bmac035. [PMID: 35453141 DOI: 10.1093/chromsci/bmac035] [Reference Citation Analysis]
14 Raja V, Farajzadegan Z, Mansourian M, Ghasemi K, Aboutalebi MS, Nouri R, Mokarian F, Maggi M. Diagnostic Value of Nonacid Nucleic Blood Tumor Marker Panels in Early Diagnosing Breast Cancer: A Systematic Review and Network Meta-Analysis. Disease Markers 2022;2022:1-15. [DOI: 10.1155/2022/4119345] [Reference Citation Analysis]
15 Crapnell RD, Garcia-miranda Ferrari A, Dempsey NC, Banks CE. Electroanalytical overview: screen-printed electrochemical sensing platforms for the detection of vital cardiac, cancer and inflammatory biomarkers. Sens Diagn 2022;1:405-28. [DOI: 10.1039/d1sd00041a] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
16 Patuleia SIS, Suijkerbuijk KPM, van der Wall E, van Diest PJ, Moelans CB. Nipple Aspirate Fluid at a Glance. Cancers (Basel) 2021;14:159. [PMID: 35008326 DOI: 10.3390/cancers14010159] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
17 Canetta E. Current and Future Advancements of Raman Spectroscopy Techniques in Cancer Nanomedicine. Int J Mol Sci 2021;22:13141. [PMID: 34884946 DOI: 10.3390/ijms222313141] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
18 Luo R, Zheng C, Song W, Tan Q, Shi Y, Han X. High-throughput and multi-phases identification of autoantibodies in diagnosing early-stage breast cancer and subtypes. Cancer Sci 2021. [PMID: 34843149 DOI: 10.1111/cas.15227] [Reference Citation Analysis]
19 Li D, Lai W, Fan D, Fang Q. Protein biomarkers in breast cancer-derived extracellular vesicles for use in liquid biopsies. Am J Physiol Cell Physiol 2021;321:C779-97. [PMID: 34495763 DOI: 10.1152/ajpcell.00048.2021] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
20 Qiong L, Yin J. Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9. Bioengineered 2021;12:8822-32. [PMID: 34654351 DOI: 10.1080/21655979.2021.1987067] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Gómez-Cebrián N, Domingo-Ortí I, Poveda JL, Vicent MJ, Puchades-Carrasco L, Pineda-Lucena A. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments. Cancers (Basel) 2021;13:4544. [PMID: 34572770 DOI: 10.3390/cancers13184544] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Giussani M, Ciniselli CM, De Cecco L, Lecchi M, Dugo M, Gargiuli C, Mariancini A, Mancinelli E, Cosentino G, Veneroni S, Paolini B, Orlandi R, Gennaro M, Iorio MV, Depretto C, Ferranti C, Sozzi G, Sensi M, Colombo MP, Scaperrotta G, Tagliabue E, Verderio P. Circulating miRNAs as Novel Non-Invasive Biomarkers to Aid the Early Diagnosis of Suspicious Breast Lesions for Which Biopsy Is Recommended. Cancers (Basel) 2021;13:4028. [PMID: 34439180 DOI: 10.3390/cancers13164028] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Bart G, Fischer D, Samoylenko A, Zhyvolozhnyi A, Stehantsev P, Miinalainen I, Kaakinen M, Nurmi T, Singh P, Kosamo S, Rannaste L, Viitala S, Hiltunen J, Vainio SJ. Characterization of nucleic acids from extracellular vesicle-enriched human sweat. BMC Genomics 2021;22:425. [PMID: 34103018 DOI: 10.1186/s12864-021-07733-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
24 Tatischeff I. Current Search through Liquid Biopsy of Effective Biomarkers for Early Cancer Diagnosis into the Rich Cargoes of Extracellular Vesicles. Int J Mol Sci 2021;22:5674. [PMID: 34073560 DOI: 10.3390/ijms22115674] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
25 Haghbin M, Hashemi Tayer A, Kamravan M, Sotoodeh Jahromi A. Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer. Asian Pac J Cancer Prev 2021;22:1573-9. [PMID: 34048188 DOI: 10.31557/APJCP.2021.22.5.1573] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Zou R, Loke SY, Tan VK, Quek ST, Jagmohan P, Tang YC, Madhukumar P, Tan BK, Yong WS, Sim Y, Lim SZ, Png E, Lee SYS, Chan MYP, Ho TSJ, Khoo BKJ, Wong SLJ, Thng CH, Chong BK, Teo YY, Too HP, Hartman M, Tan NC, Tan EY, Lee SC, Zhou L, Lee ASG. Development of a microRNA Panel for Classification of Abnormal Mammograms for Breast Cancer. Cancers (Basel) 2021;13:2130. [PMID: 33925125 DOI: 10.3390/cancers13092130] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
27 Rodríguez-Aguilar M, Díaz de León-Martínez L, Gorocica-Rosete P, Pérez-Padilla R, Domínguez-Reyes CA, Tenorio-Torres JA, Ornelas-Rebolledo O, Mehta G, Zamora-Mendoza BN, Flores-Ramírez R. Application of chemoresistive gas sensors and chemometric analysis to differentiate the fingerprints of global volatile organic compounds from diseases. Preliminary results of COPD, lung cancer and breast cancer. Clin Chim Acta 2021;518:83-92. [PMID: 33766555 DOI: 10.1016/j.cca.2021.03.016] [Cited by in Crossref: 5] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
28 He J, Fortunati E, Liu DX, Li Y. Pleiotropic Roles of ABC Transporters in Breast Cancer. Int J Mol Sci 2021;22:3199. [PMID: 33801148 DOI: 10.3390/ijms22063199] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
29 Hong CQ, Weng XF, Huang XC, Chu LY, Wei LF, Lin YW, Chen LY, Liu CT, Xu YW, Peng YH. A Panel of Tumor-associated Autoantibodies for the Detection of Early-stage Breast Cancer. J Cancer 2021;12:2747-55. [PMID: 33854634 DOI: 10.7150/jca.57019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
30 Piskór BM, Przylipiak A, Dąbrowska E, Sidorkiewicz I, Niczyporuk M, Szmitkowski M, Ławicki S. Plasma Level of MMP-10 May Be a Prognostic Marker in Early Stages of Breast Cancer. J Clin Med 2020;9:E4122. [PMID: 33371324 DOI: 10.3390/jcm9124122] [Reference Citation Analysis]